Type 2 diabetes

Type 2 diabetes mellitus

Find reliable independent health and treatment information about type 2 diabetes written by Australian experts. This includes resources for consumers and health professionals. We also have information and resources for type 1 diabetes.

About type 2 diabetes

Almost one million people in Australia have type 2 diabetes, that's about 1 in every 20 Australians.

Type 2 diabetes is a metabolic condition that affects your body’s ability to regulate the amount of glucose (a type of sugar) in your blood.

High blood glucose levels can cause a range of different symptoms, and — over time — complications, if your diabetes is not monitored and managed.

Type 2 diabetes can be successfully managed using lifestyle measures and medicines, and the more you know about your condition, the better.

Find out more

For health professionals  

While good glycaemic control is important in the long term, addressing lifestyle factors, blood pressure and blood lipids is essential in the early stages. The prevalence of type 2 diabetes, and the associated cardiovascular diseases, is increasing in Australia. Diabetes impacts quality of life and life expectancy as a result of microvascular complications and the increased risk of macrovascular complications.

Our CPD activities

Consolidate your knowledge on type 2 diabetes, brush-up on current guidelines and practices and earn CPD points through our continuing professional development activities.

For your patients

Use the following tools and resources in your patient consultations.

Clinical information

The information below is intended for health professionals. It uses the latest guidelines and evidence to help health professionals further understand the issues around the management of type 2 diabetes. It also includes resources to help educate patients and carers.

Other tools and resources


Related information - type 2 diabetes

Audience:
       

(Medicine)
22 Sep 2016 Find out about Glybosay Tablets. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
22 Sep 2016 Chemmart Gliclazide MR Modified release tablets is a brand of medicine containing the active ingredient gliclazide. Find out about side effects, who can take it and who shouldn’t use Chemmart Gliclazide MR Modified release tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Medicine)
22 Sep 2016 Diamicron 60mg MR Modified release tablets is a brand of medicine. Find out about side effects, who can and who shouldn’t use Diamicron 60mg MR Modified release tablets by reading the latest Australian consumer medicine information. See our tips on how to use medicines wisely and safely.
(Medicine)
22 Sep 2016 Minidiab Tablets is a brand of medicine containing the active ingredient glipizide. Find out about side effects, who can take it and who shouldn’t use Minidiab Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Tool / resource)
06 Sep 2016 If you have diabetes, find out why managing your blood pressure and cholesterol are just as important as managing your blood glucose (sugar) levels.
(Medicine)
20 Jul 2016 Find out about Formet Tablets. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
20 Jul 2016 Find out about Actaze Tablets. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
20 Jul 2016 Diaformin XR Extended release tablets is a brand of medicine containing the active ingredient metformin hydrochloride. Find out about side effects, who can take it and who shouldn’t use Diaformin XR Extended release tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Media release)
14 Jul 2016 New type 2 diabetes patient decision aid to improve medicine adherence issues: from NPS MedicineWise.
(Media release)
13 Jul 2016 A new survey* of Australians living with type 2 diabetes—released by NPS MedicineWise during National Diabetes Week—has shown more than one in four (28%) admit that they miss doses of their diabetes medicines.